3 COVID-19 Stocks That Should Beat the Market in 2022
We are all ready to move past COVID and return to normality. Nonetheless, there's a new variant in town called Omicron, and we don't know yet how serious or not-serious this variant will be. The last highly contagious variant was Delta, and there were several other not-so-serious variants discovered between Delta and Omicron.
What stocks should we buy when we don't know how dangerous this new variant will be? Our Foolish writers suggest you take a look at Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and Inari Medical (NASDAQ: NARI). Here's why.
Image source: Getty Images.
Source Fool.com
